Neogen Corporation (NEOG)
USD 11.64
(-4.04%)
USD 11.64
(-4.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 463.9 Million USD | 14.27% |
| 2023 | 405.95 Million USD | 67.05% |
| 2022 | 243.01 Million USD | 13.0% |
| 2021 | 215.05 Million USD | 9.57% |
| 2020 | 196.27 Million USD | 2.27% |
| 2019 | 191.92 Million USD | 0.88% |
| 2018 | 190.25 Million USD | 10.63% |
| 2017 | 171.96 Million USD | 12.35% |
| 2016 | 153.06 Million USD | 9.58% |
| 2015 | 139.68 Million USD | 13.94% |
| 2014 | 122.59 Million USD | 11.97% |
| 2013 | 109.49 Million USD | 18.47% |
| 2012 | 92.42 Million USD | 5.28% |
| 2011 | 87.79 Million USD | 20.3% |
| 2010 | 72.97 Million USD | 22.79% |
| 2009 | 59.43 Million USD | 11.65% |
| 2008 | 53.23 Million USD | 19.46% |
| 2007 | 44.56 Million USD | 20.42% |
| 2006 | 37 Million USD | 20.92% |
| 2005 | 30.6 Million USD | 11.25% |
| 2004 | 27.5 Million USD | 11.26% |
| 2003 | 24.72 Million USD | 18.3% |
| 2002 | 20.9 Million USD | 17.83% |
| 2001 | 17.73 Million USD | 30.45% |
| 2000 | 13.59 Million USD | -0.01% |
| 1999 | 13.6 Million USD | 20.35% |
| 1998 | 11.3 Million USD | 16.49% |
| 1997 | 9.7 Million USD | 29.33% |
| 1996 | 7.5 Million USD | 7.14% |
| 1995 | 7 Million USD | 9.38% |
| 1994 | 6.4 Million USD | 56.1% |
| 1993 | 4.1 Million USD | 28.13% |
| 1992 | 3.2 Million USD | 10.34% |
| 1991 | 2.9 Million USD | 0.0% |
| 1990 | 2.9 Million USD | -9.38% |
| 1989 | 3.2 Million USD | 52.38% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 116.88 Million USD | 0.09% |
| 2024 Q2 | 116.77 Million USD | 0.01% |
| 2024 Q4 | 113.48 Million USD | -2.91% |
| 2024 Q1 | 116.76 Million USD | -5.21% |
| 2024 FY | 462.63 Million USD | 13.96% |
| 2023 Q1 | 62.27 Million USD | -4.2% |
| 2023 Q2 | 112.53 Million USD | 80.73% |
| 2023 FY | 405.95 Million USD | 67.05% |
| 2023 Q3 | 107.96 Million USD | -4.07% |
| 2023 Q4 | 123.18 Million USD | 14.1% |
| 2022 Q3 | 57.41 Million USD | -5.25% |
| 2022 Q1 | 60 Million USD | 4.02% |
| 2022 Q4 | 64.99 Million USD | 13.22% |
| 2022 FY | 243.01 Million USD | 13.0% |
| 2022 Q2 | 60.59 Million USD | 0.98% |
| 2021 Q3 | 53.84 Million USD | 1.19% |
| 2021 FY | 215.05 Million USD | 9.57% |
| 2021 Q4 | 57.69 Million USD | 7.13% |
| 2021 Q2 | 53.21 Million USD | 5.79% |
| 2021 Q1 | 50.3 Million USD | -2.76% |
| 2020 Q4 | 51.72 Million USD | 14.12% |
| 2020 FY | 196.27 Million USD | 2.27% |
| 2020 Q1 | 48.19 Million USD | -4.62% |
| 2020 Q2 | 51.02 Million USD | 5.88% |
| 2020 Q3 | 45.33 Million USD | -11.16% |
| 2019 Q2 | 50.03 Million USD | 7.07% |
| 2019 Q1 | 46.72 Million USD | -5.77% |
| 2019 Q4 | 50.53 Million USD | 13.22% |
| 2019 Q3 | 44.62 Million USD | -10.8% |
| 2019 FY | 191.92 Million USD | 0.88% |
| 2018 Q1 | 45.87 Million USD | -2.44% |
| 2018 Q4 | 49.58 Million USD | 8.94% |
| 2018 Q3 | 45.52 Million USD | -7.61% |
| 2018 Q2 | 49.27 Million USD | 7.41% |
| 2018 FY | 190.25 Million USD | 10.63% |
| 2017 Q2 | 43.59 Million USD | 7.69% |
| 2017 FY | 171.96 Million USD | 12.35% |
| 2017 Q3 | 40.88 Million USD | -6.22% |
| 2017 Q4 | 47.01 Million USD | 15.01% |
| 2017 Q1 | 40.47 Million USD | -3.28% |
| 2016 FY | 153.06 Million USD | 9.58% |
| 2016 Q4 | 41.85 Million USD | 18.91% |
| 2016 Q1 | 37.79 Million USD | 0.25% |
| 2016 Q2 | 38.22 Million USD | 1.14% |
| 2016 Q3 | 35.19 Million USD | -7.92% |
| 2015 FY | 139.68 Million USD | 13.94% |
| 2015 Q4 | 37.69 Million USD | 11.85% |
| 2015 Q2 | 34.2 Million USD | 0.39% |
| 2015 Q3 | 33.7 Million USD | -1.48% |
| 2015 Q1 | 34.07 Million USD | 6.36% |
| 2014 Q3 | 30.7 Million USD | 4.12% |
| 2014 FY | 122.59 Million USD | 11.97% |
| 2014 Q1 | 30.36 Million USD | 6.99% |
| 2014 Q2 | 29.49 Million USD | -2.88% |
| 2014 Q4 | 32.03 Million USD | 4.34% |
| 2013 Q2 | 27.3 Million USD | 3.06% |
| 2013 Q4 | 28.38 Million USD | 3.91% |
| 2013 FY | 109.49 Million USD | 18.47% |
| 2013 Q1 | 26.49 Million USD | 10.86% |
| 2013 Q3 | 27.31 Million USD | 0.03% |
| 2012 Q2 | 22.65 Million USD | -1.39% |
| 2012 FY | 92.42 Million USD | 5.28% |
| 2012 Q4 | 23.89 Million USD | 4.4% |
| 2012 Q3 | 22.89 Million USD | 1.04% |
| 2012 Q1 | 22.97 Million USD | 4.68% |
| 2011 Q1 | 22.76 Million USD | 15.44% |
| 2011 Q2 | 22.48 Million USD | -1.23% |
| 2011 Q3 | 20.58 Million USD | -8.45% |
| 2011 Q4 | 21.94 Million USD | 6.61% |
| 2011 FY | 87.79 Million USD | 20.3% |
| 2010 Q4 | 19.72 Million USD | 12.95% |
| 2010 Q1 | 17.27 Million USD | 11.58% |
| 2010 Q2 | 18.52 Million USD | 7.25% |
| 2010 Q3 | 17.46 Million USD | -5.73% |
| 2010 FY | 72.97 Million USD | 22.79% |
| 2009 Q1 | 14.8 Million USD | 4.98% |
| 2009 FY | 59.43 Million USD | 11.65% |
| 2009 Q2 | 16.12 Million USD | 8.92% |
| 2009 Q3 | 13.02 Million USD | -19.21% |
| 2009 Q4 | 15.47 Million USD | 18.81% |
| 2008 Q3 | 12.66 Million USD | -10.64% |
| 2008 Q4 | 14.1 Million USD | 11.36% |
| 2008 FY | 53.23 Million USD | 19.46% |
| 2008 Q1 | 12.29 Million USD | 6.16% |
| 2008 Q2 | 14.17 Million USD | 15.24% |
| 2007 FY | 44.56 Million USD | 20.42% |
| 2007 Q4 | 11.58 Million USD | 5.79% |
| 2007 Q3 | 10.95 Million USD | -6.47% |
| 2007 Q2 | 11.7 Million USD | 13.45% |
| 2007 Q1 | 10.32 Million USD | 1.64% |
| 2006 Q1 | 8.84 Million USD | 9.88% |
| 2006 Q2 | 9.49 Million USD | 7.34% |
| 2006 Q3 | 8.52 Million USD | -10.21% |
| 2006 Q4 | 10.15 Million USD | 19.15% |
| 2006 FY | 37 Million USD | 20.92% |
| 2005 Q4 | 8.04 Million USD | 15.64% |
| 2005 Q3 | 6.95 Million USD | -14.04% |
| 2005 Q2 | 8.09 Million USD | 7.85% |
| 2005 Q1 | 7.5 Million USD | 2.53% |
| 2005 FY | 30.6 Million USD | 11.25% |
| 2004 Q1 | 6.26 Million USD | -3.08% |
| 2004 FY | 27.5 Million USD | 11.26% |
| 2004 Q4 | 7.32 Million USD | 5.69% |
| 2004 Q3 | 6.92 Million USD | -1.1% |
| 2004 Q2 | 7 Million USD | 11.87% |
| 2003 Q1 | 5.81 Million USD | 1.71% |
| 2003 Q2 | 6.7 Million USD | 15.32% |
| 2003 Q3 | 5.74 Million USD | -14.42% |
| 2003 Q4 | 6.45 Million USD | 12.51% |
| 2003 FY | 24.72 Million USD | 18.3% |
| 2002 Q1 | 4.89 Million USD | 0.95% |
| 2002 Q3 | 4.61 Million USD | -18.61% |
| 2002 Q4 | 5.71 Million USD | 23.87% |
| 2002 Q2 | 5.67 Million USD | 15.96% |
| 2002 FY | 20.9 Million USD | 17.83% |
| 2001 Q1 | 3.99 Million USD | 20.22% |
| 2001 Q2 | 4.54 Million USD | 13.71% |
| 2001 Q3 | 4.35 Million USD | -4.23% |
| 2001 Q4 | 4.84 Million USD | 11.35% |
| 2001 FY | 17.73 Million USD | 30.45% |
| 2000 Q1 | 3.2 Million USD | 3.23% |
| 2000 FY | 13.59 Million USD | -0.01% |
| 2000 Q4 | 3.32 Million USD | -13.05% |
| 2000 Q3 | 3.82 Million USD | 23.32% |
| 2000 Q2 | 3.1 Million USD | -3.13% |
| 1999 Q3 | 3.3 Million USD | -5.71% |
| 1999 FY | 13.6 Million USD | 20.35% |
| 1999 Q1 | 3.7 Million USD | 23.33% |
| 1999 Q2 | 3.5 Million USD | -5.41% |
| 1999 Q4 | 3.1 Million USD | -6.06% |
| 1998 Q3 | 2.7 Million USD | -6.9% |
| 1998 Q4 | 3 Million USD | 11.11% |
| 1998 FY | 11.3 Million USD | 16.49% |
| 1998 Q2 | 2.9 Million USD | 7.41% |
| 1998 Q1 | 2.7 Million USD | 12.5% |
| 1997 Q2 | 2.5 Million USD | -3.85% |
| 1997 FY | 9.7 Million USD | 29.33% |
| 1997 Q4 | 2.4 Million USD | 9.09% |
| 1997 Q1 | 2.6 Million USD | 44.44% |
| 1997 Q3 | 2.2 Million USD | -12.0% |
| 1996 Q4 | 1.8 Million USD | 0.0% |
| 1996 FY | 7.5 Million USD | 7.14% |
| 1996 Q3 | 1.8 Million USD | -10.0% |
| 1996 Q2 | 2 Million USD | 11.11% |
| 1996 Q1 | 1.8 Million USD | -41.94% |
| 1995 Q1 | 2.6 Million USD | -3.7% |
| 1995 Q2 | 2.9 Million USD | 11.54% |
| 1995 Q3 | 3 Million USD | 3.45% |
| 1995 FY | 7 Million USD | 9.38% |
| 1995 Q4 | 3.1 Million USD | 3.33% |
| 1994 FY | 6.4 Million USD | 56.1% |
| 1994 Q2 | 1.9 Million USD | 46.15% |
| 1994 Q3 | 2.7 Million USD | 42.11% |
| 1994 Q4 | 2.7 Million USD | 0.0% |
| 1994 Q1 | 1.3 Million USD | -40.91% |
| 1993 FY | 4.1 Million USD | 28.13% |
| 1993 Q4 | 2.2 Million USD | 4.76% |
| 1993 Q3 | 2.1 Million USD | 10.53% |
| 1993 Q2 | 1.9 Million USD | 137.5% |
| 1993 Q1 | 800 Thousand USD | -55.56% |
| 1992 Q4 | 1.8 Million USD | 0.0% |
| 1992 FY | 3.2 Million USD | 10.34% |
| 1992 Q3 | 1.8 Million USD | 5.88% |
| 1992 Q2 | 1.7 Million USD | 30.77% |
| 1992 Q1 | 1.3 Million USD | -31.58% |
| 1991 Q2 | 1.5 Million USD | 36.36% |
| 1991 Q3 | 1.5 Million USD | 0.0% |
| 1991 FY | 2.9 Million USD | 0.0% |
| 1991 Q4 | 1.9 Million USD | 26.67% |
| 1991 Q1 | 1.1 Million USD | -31.25% |
| 1990 Q1 | 1.2 Million USD | -25.0% |
| 1990 Q3 | 1.4 Million USD | -12.5% |
| 1990 Q2 | 1.6 Million USD | 33.33% |
| 1990 Q4 | 1.6 Million USD | 14.29% |
| 1990 FY | 2.9 Million USD | -9.38% |
| 1989 Q3 | 1.5 Million USD | -6.25% |
| 1989 FY | 3.2 Million USD | 52.38% |
| 1989 Q4 | 1.6 Million USD | 6.67% |
| 1989 Q1 | 1.5 Million USD | 25.0% |
| 1989 Q2 | 1.6 Million USD | 6.67% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | -4749.467% |
| Prenetics Global Limited | 8.82 Million USD | -5153.748% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -3789.821% |
| CareDx, Inc | 178.32 Million USD | -160.143% |
| Exact Sciences Corporation | 1.84 Billion USD | 74.863% |
| Exagen Inc. | 29.45 Million USD | -1474.891% |
| Inotiv, Inc. | 165.44 Million USD | -180.399% |
| Guardant Health, Inc. | 336.89 Million USD | -37.698% |
| Biodesix, Inc. | 36.07 Million USD | -1185.861% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | -34792.869% |
| Precipio, Inc. | 6.01 Million USD | -7608.541% |
| iSpecimen Inc. | 5.1 Million USD | -8981.982% |
| Natera, Inc. | 492.74 Million USD | 5.853% |
| Aspira Women's Health Inc. | 5.26 Million USD | -8716.04% |
| Standard BioTools Inc. | 50.45 Million USD | -819.524% |
| 23andMe Holding Co. | 99.37 Million USD | -366.808% |
| Castle Biosciences, Inc. | 174.8 Million USD | -165.38% |
| Personalis, Inc. | 18.2 Million USD | -2447.781% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | -3422.934% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | -8283.585% |
| OpGen, Inc. | -90.69 Thousand USD | 511600.209% |
| T2 Biosystems, Inc. | -8.17 Million USD | 5778.091% |
| Myriad Genetics, Inc. | 476.4 Million USD | 2.624% |
| ICON Public Limited Company | 1.81 Billion USD | 74.431% |
| NeoGenomics, Inc. | 244.6 Million USD | -89.653% |
| Star Equity Holdings, Inc. | 11.92 Million USD | -3789.821% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 78.817% |
| RadNet, Inc. | 93 Million USD | -398.817% |
| MDxHealth SA | 43.92 Million USD | -956.022% |
| Psychemedics Corporation | 8.41 Million USD | -5414.085% |
| Illumina, Inc. | 2.74 Billion USD | 83.094% |
| Check-Cap Ltd. | -212 Thousand USD | 218920.755% |
| Twist Bioscience Corporation | 133.34 Million USD | -247.884% |
| DarioHealth Corp. | 5.98 Million USD | -7652.34% |
| Fulgent Genetics, Inc. | 104.45 Million USD | -344.11% |
| Sera Prognostics, Inc. | 96 Thousand USD | -483129.167% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | 168514.709% |
| OPKO Health, Inc. | 318.12 Million USD | -45.822% |
| Medpace Holdings, Inc. | 524.5 Million USD | 11.555% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | -32440.091% |
| Prenetics Global Limited | 8.82 Million USD | -5153.748% |
| Mainz Biomed B.V. | 509.65 Thousand USD | -90921.644% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -58501.719% |
| Trinity Biotech plc | 19.45 Million USD | -2285.09% |
| Neuronetics, Inc. | 51.7 Million USD | -797.205% |
| Sotera Health Company | 577.15 Million USD | 19.623% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | -58501.719% |